Development

Northway Biotechpharma collaborates with a Swiss company on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19

pagal

Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to develop a fast-track manufacturing path for MTx’s therapeutic COVID-19 antibody candidate. MTx today announces a collaboration with Northway to establish … Skaityti toliau

GSB Gold Standard Corporation, Josip Heit and the Blockchain Technology

pagal

The blockchain technology is one of the most discussed innovations of the digital transformation of economy and society, which is comprehensively implemented by GSB Gold Standard Banking Corporation AG. According to Josip Heit, this is the only reasonable way for the future, from an uncontrolled to a sustainable regulated market. With features such as decentralisation, … Skaityti toliau

WSSCC approved to become the Sanitation and Hygiene Fund

pagal

GENEVA, 6 May 2020 – The Steering Committee of the Water Supply and Sanitation Collaborative Council (WSSCC) took a landmark decision on Monday by approving WSSCC’s new 2021-2025 strategy, which paves the way for WSSCC to evolve into the Sanitation and Hygiene Fund, a scalable and global Fund to effectively support the world’s poorest and … Skaityti toliau

Aptorum Group Collaborates with Covar Pharmaceuticals To Investigate at Least 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform

pagal

NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM) („Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is initiating an additional research and development project targeting the coronavirus group and has completed initial screening under … Skaityti toliau

Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020

pagal

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in relation to its repurposed drug candidate, SACT-1, for the treatment of neuroblastoma, a rare type of childhood cancer that develops in infants and young children. Subject … Skaityti toliau

The sea wind will drive green energy in the Baltic States – an analysis of the European Copper Institute

pagal

Offshore wind energy will be one of the key directions of modernization of the energy system in the Baltic States. The increase in the share of green energy in total consumption is a requirement of the European Union’s climate policy. Lithuania, Latvia and Estonia have already achieved or are close to achieving the 2020 renewable … Skaityti toliau

IT specialistų rinka Baltijos šalyse: Lietuva vejasi pirmaujančią Rygą

pagal

Lietuva laikoma Baltijos šalių IT centru, tačiau kaip rodo naujausi tyrimo duomenys, pagal programuotojų skaičių Vilnių ir Kauną kartu sudėjus lenkia mūsų artimiausios kaimynės Latvijos sostinė Ryga. Vilniaus ir Kauno universitetai parengia daugiausia IT specialistų Baltijos šalyse. Tačiau šioje srityje dirbančių žmonių skaičiumi Lietuvos didmiesčiai atsilieka nuo Rygos ir Talino. Kaip rodo tarptautinės bendrovės „Software … Skaityti toliau

Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent

pagal

May 15, 2019 02:06 AM Eastern Daylight Time DUBLIN–(BUSINESS WIRE)–Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents. Medtronic’s Gastrointestinal and … Skaityti toliau

Half-Year Figures: ZEISS Innovations Help Achieve Strong Growth

pagal

OBERKOCHEN, 7 May 2019   The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 (ended 31 March 2019) and saw its revenue rise by 9 percent to EUR 3.019 billion (1st six months of 2017/18: EUR 2.773 billion). At EUR 443 million, earnings before interest and tax (EBIT) were significantly … Skaityti toliau

Mary Kay Inc. Announces Two Executive Appointments in Supply Chain Operations

pagal

Global Beauty Brand Appoints Chaun Harper and Dr. Lucy Gildea to Executive Team In their new roles, Chaun Harper and Lucy Gildea will join the global cosmetics company’s executive team. (Photo: Mary Kay Inc.)   January 24, 2019 08:12 AM Eastern Standard Time DALLAS–(BUSINESS WIRE)–Mary Kay Inc., celebrating its 55th anniversary as a top beauty brand … Skaityti toliau